North America Monoclonal Antibodies Market to 2030 - by Source, Category, Production Type, Application, End-user and Country - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "North America Monoclonal Antibodies Market 2020-2030 by Source, Category, Production Type, Application, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

The North American monoclonal antibodies market is projected to grow by 10.4% annually in the forecast period and reach $133.4 billion by 2030, driven by the increasing incidences of new cancer cases and other diseases, growth in geriatric population, increasing pharmaceutical R&D spending, upsurge in healthcare expenditure, and the rising adoption of cost-efficient biosimilar monoclonal antibodies.

This report is based on a comprehensive research of the entire North America monoclonal antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19

Companies Mentioned

• Abbott Laboratories
• AbbVie, Inc.
• Amgen Inc.
• AstraZeneca plc
• Bayer AG
• Bristol-Myers Squibb Company
• Eli Lilly
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co., Inc.
• Mylan N.V
• Norvatis AG
• Pfizer
• Sanofi S.A.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America monoclonal antibodies market in every aspect of the classification from perspectives of Source, Category, Production Type, Application, End User, and Country.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of Covid-19 on World Economy

2.1.2 Impact of Covid-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter's Five Forces Analysis

3 Segmentation of North America Market by Source

3.1 Market Overview by Source

3.2 Human

3.3 Humanized

3.4 Chimeric

3.5 Murine

4 Segmentation of North America Market by Category

4.1 Market Overview by Category

4.2 Branded Mabs

4.3 Biosimilar Mabs

5 Segmentation of North America Market by Production Type

5.1 Market Overview by Production Type

5.2 in Vitro Production

5.3 in Vivo Production

6 Segmentation of North America Market by Application

6.1 Market Overview by Application

6.2 Cancer

6.2.1 Breast Cancer

6.2.2 Colorectal Cancer

6.2.3 Lung Cancer

6.2.4 Ovarian Cancer

6.2.5 Other Cancer Types

6.3 Autoimmune Diseases

6.4 Inflammatory Diseases

6.5 Infectious Diseases

6.6 Other Applications

7 Segmentation of North America Market by End-user

7.1 Market Overview by End-user

7.2 Hospitals

7.3 Research Institutes

7.4 Other End-users

8 North America Market 2019-2030 by Country

8.1 Overview of North America Market

8.2 U.S.

8.3 Canada

8.4 Mexico

9 Competitive Landscape

9.1 Overview of Key Vendors

9.2 New Product Launch, Partnership, Investment, and M&A

9.3 Company Profiles

• Abbott Laboratories
• Abbvie, Inc.
• Amgen Inc.
• Astrazeneca plc
• Bayer Ag
• Bristol-Myers Squibb Company
• Eli Lilly
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck & Co. Inc.
• Mylan N.V
• Norvatis Ag
• Pfizer
• Sanofi S.A.
• Related Reports

For more information about this report visit https://www.researchandmarkets.com/r/bqw207

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900